Keefe Bruyette lowered the firm’s price target on MetLife (MET) to $90 from $92 and keeps an Outperform rating on the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife price target lowered to $92 from $96 at Wells Fargo
- MetLife Reports Strong Q3 2025 Earnings Growth
- MetLife’s Earnings Call Highlights Strong Growth and Strategic Focus
- M&A News: Brighthouse Stock (BHF) Jumps through the Roof on $4.1B Acquisition Deal
- MetLife’s Strong Earnings and Resilient Business Model Drive Buy Rating
